Yüklüyor......
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Vandetanib (ZD6474) is an oral small molecule inhibitor of multiple intracellular receptor kinases, including the vascular endothelial growth factor receptor (VEGFR) -2 and epidermal growth factor receptor (EGFR). Both VEGFR and EGFR pathways have emerged as instrumental in the growth and metastasis...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2943196/ https://ncbi.nlm.nih.gov/pubmed/20859451 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|